Adam J. Greenlee
Known title: President and CEOCIK: 0001412971
Adam J. Greenlee's purchase track record
Adam J. Greenlee has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/31/2025 | SLGN | $267K | +12.3% | +3.9% | +5.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SLGN | ▼ Sell | Tax Withholding | 57,047 | $2.7M | 3/1/2026 | View on chart |
| SLGN | ▲ Buy | Grant | 64,900 | — | 3/1/2026 | View on chart |
| SLGN | ▲ Buy | Grant | 105,000 | — | 2/26/2026 | View on chart |
| SLGN | ▲ Buy | Open Market | 7,000 | $267K | 10/31/2025 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 42,868 | $2.3M | 3/1/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 70,700 | — | 3/1/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 66,000 | — | 2/27/2025 | View on chart |
| SLGN | ▼ Sell | Open Market | 125,000 | $6.8M | 2/24/2025 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 33,666 | $1.5M | 3/1/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 44,800 | — | 3/1/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 70,000 | — | 2/28/2024 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 30,432 | $1.6M | 3/1/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 66,300 | — | 2/22/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 47,000 | — | 2/22/2023 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 32,828 | $1.4M | 3/1/2022 | View on chart |
| SLGN | ▲ Buy | Grant | 25,100 | — | 3/1/2022 | View on chart |
| SLGN | ▲ Buy | Grant | 26,500 | — | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating
UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating. UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.